| |
|
|
|
Pacific Biosciences of California Inc.  
|
|
4.81 -0.04 (-0.01%) |
09-21 16:00 |
|
Open: |
4.84 |
Pre close: |
4.85 |
Target:
|
6.33
|
|
High: |
4.9 |
Low: |
4.7 |
Resistance:
|
5.42
6.33
|
|
Volume: |
1,631,202 |
Market Cap: |
702M |
Support:
|
4.58
4.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.95
 |
MACD |
MACD(12,26):
|
0.19 |
|
MA(20): |
4.78  |
Signal(12,26,9): |
0.22 |
|
MA(100): |
3.67 |
Stochastic Oscillator |
%K(14,3):
|
53.83 |
|
MA(250): |
3.29 |
%D(3): |
61.02 |
|
Average Volume(K) |
3-Month: |
102674
|
52-Week |
High:
|
5.58 |
|
10-Days: |
189623 |
Low: |
2.02 |
|
RSI |
RSI(14):
|
54.77 |
Change(%): |
-5.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.740 |
Return on Equity (ttm) |
-87.8 |
Shares Out. (M) |
131.94 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-56.1 |
Shares Float (M) |
128.26 |
|
EPS Est. Next Year |
-0.640 |
PEG Ratio |
-0.25 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
7.5 |
% Held by Institutions |
65.70 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.134 |
Shares Short (K) |
9403 |
|
Book Value (p.s.) |
7.900 |
EBITDA (p.s.) |
-0.301 |
P/E |
-6.50 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.61 |
|
Profit Margin |
-98.16 |
Operating Cash Flow
(M) |
-71.31 |
P/S |
869358080.00 |
|
Operating Margin |
-98.18 |
Levered Free Cash Flow
(M) |
-46.67 |
P/CF |
-8.90 |
|
|
|
|
|
|
